Furthermore, consistent with the results obtained from miR-1291-expressing pancreatic cancer cells (this study), both FOXA2 and AGR2 protein levels were reduced in cells after transient transfection with miR-1291 expression plasmids (data not shown) or bioengineered miR-1291 agent [31]. This evidence concerns the gene FOXA2 and familial pancreatic carcinoma.